{"nct_id":"NCT00946647","title":"A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).","status":"COMPLETED","status_verified_date":"2020-07","start_date":"2009-12-02","start_date_type":"ACTUAL","primary_completion_date":"2019-04-29","primary_completion_date_type":"ACTUAL","completion_date":"2019-04-29","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}